Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 1
Submit an article Journal homepage
981
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials

Rizwana ParveenCentre for Translational and Clinical Research, Jamia Hamdard, New Delhi110062, India
,
Nidhi Bharal AgarwalCentre for Translational and Clinical Research, Jamia Hamdard, New Delhi110062, IndiaCorrespondence[email protected]
,
Neelam KaushalMedical Affairs and Clinical Research, Sun Pharma Industries Ltd., Gurgaon122001, India
,
Ghanshyam MaliMedical Affairs and Clinical Research, Sun Pharma Industries Ltd., Gurgaon122001, India
&
Sheikh RaisuddinCentre for Translational and Clinical Research, Jamia Hamdard, New Delhi110062, India
Pages 105-115 | Published online: 09 Dec 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

David S. Kountz. (2017) The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations. Postgraduate Medicine 129:4, pages 421-429.
Read now
Curt J. Carlson & Marile L. Santamarina. (2016) Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus. Expert Opinion on Drug Safety 15:10, pages 1401-1412.
Read now

Articles from other publishers (5)

Mani Pathak, Rizwana Parveen, Parvej Khan, Nilanjan Saha & Nidhi Agarwal. (2023) Impact of tofogliflozin on hepatic outcomes: a systematic review. European Journal of Clinical Pharmacology.
Crossref
Matthew J. Budoff, Timothy M. E. Davis, Alexandra G. Palmer, Robert Frederich, David E. Lawrence, Jie Liu, Ira Gantz & Giuseppe Derosa. (2021) Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV. Diabetes Therapy 12:5, pages 1279-1297.
Crossref
Gang Chen, Dan Zhang, Aihua Du, Yanan Zhang, Ying Zhang, Lina Zhang, Siqi Zang, Xiaona Liu, Zejuan Wang, Haiqing Zhen, Yujing Liu, Shuya Yang & Jin Wang. (2020) Pharmacokinetics, Safety, and Bioequivalence of Two Empagliflozin Formulations after Single Oral Administration under Fasting and Fed Conditions in Healthy Chinese Subjects: An Open‐label Randomized Single‐dose Two‐sequence, Two‐treatment, Two‐period Crossover Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:7, pages 623-631.
Crossref
Katsura Niijima, Yawara Niijima, Shuichi Okada & Masanobu Yamada. (2017) Drug-induced Liver Injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report. Annals of Hepatology 16:2, pages 308-311.
Crossref
A.J. Scheen. (2016) Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics. Diabetes & Metabolism 42:4, pages 224-233.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.